Xcopri 200 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FQJSL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,809
Award facts
- Contract value 100% obligated
- $3,809.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,809.28 by the Defense Logistics Agency (DLA) on September 15, 2025, for the supply of Xcopri 200 mg tablets (30-count packaging). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 16, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026.
The DLA, operating under the Department of Defense, procures pharmaceuticals and medical supplies to support military healthcare operations globally. AmerisourceBergen Drug Corp, as a major pharmaceutical distributor and established federal contractor, supplies a broad portfolio of brand-name and generic medications, vaccines, and medical devices across multiple therapeutic categories to Defense Health Agency facilities and other federal healthcare systems. This particular delivery order for Xcopri, a neurological medication, exemplifies the company's role in fulfilling specialized pharmaceutical requirements within the DLA's comprehensive medical supply chain. The SPE2DX prime vendor contract under which this order was issued represents a strategic sourcing vehicle enabling flexible, efficient procurement of critical medications for military healthcare worldwide.
Quick answers
Who was awarded contract SPE2DB25FQJSL?
SPE2DB25FQJSL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FQJSL worth?
The government has obligated $3,809 on SPE2DB25FQJSL.
Is contract SPE2DB25FQJSL an order under another contract?
Yes. SPE2DB25FQJSL is a delivery order under SPE2DB25D3005, an indefinite delivery contract.
Was contract SPE2DB25FQJSL competed?
The extent of competition for SPE2DB25FQJSL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award